Literature DB >> 30659519

The PIRP project (Prevenzione Insufficienza Renale Progressiva): how to integrate hospital and community maintenance treatment for chronic kidney disease.

Antonio Santoro1, Dino Gibertoni2, Paola Rucci2, Elena Mancini3, Decenzio Bonucchi4, Andrea Buscaroli5, Anselmo Campagna6, Gianni Cappelli7, Salvatore David8, Maria Cristina Gregorini9, Gaetano La Manna10, Giovanni Mosconi11,12, Angelo Rigotti13, Roberto Scarpioni14, Alda Storari15, Marcora Mandreoli16.   

Abstract

Chronic kidney disease (CKD) represents a global health burden with great economic impact on healthcare and therefore it requires appropriate interventions by Health Care Systems. The PIRP (Prevenzione Insufficienza Renale Progressiva) project is endorsed and funded by the Emilia-Romagna Regional Health Board and involves all the Nephrology Units of the Emilia-Romagna Region (Italy). The project has a predominantly clinical purpose and is expected to bring about a continuous quality improvement in the treatment of patients with CKD. Its aims are to intercept patients in an early phase of CKD, to delay their illness progression and to prevent cardiovascular complications. An integrated care pathway involving nephrologists, general practitioners (GPs) and other specialists has been created to identify patients to whom ambulatory care targeted on effective, efficient pharmaceutical and dietary treatment as well as on lifestyle modifications is subsequently provided. With the cooperation of GPs, in its 13 years of activity the project identified and followed up more than 25,000 CKD patients, who attended the Nephrology units with more than 100,000 visits. The effects of a closer and joint monitoring of CKD patients by GPs and nephrologists can be quantified by the reduction of the mean annual GFR decline (average annual CKD-EPI change: - 0.34 ml/min), and by the decrease in the overall incidence of patients who annually started dialysis in the Emilia-Romagna Region, that dropped from 218.6 (× million) in 2006 to 197.5 (× million) in 2016, corresponding to about 100 cases.

Entities:  

Keywords:  CKD management; Chronic kidney disease; General Practitioners; Public health intervention; Registries; eGFR

Year:  2019        PMID: 30659519     DOI: 10.1007/s40620-018-00570-2

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  25 in total

1.  Impact of timing of nephrology referral and pre-ESRD care on mortality risk among new ESRD patients in the United States.

Authors:  Austin G Stack
Journal:  Am J Kidney Dis       Date:  2003-02       Impact factor: 8.860

2.  Early detection of chronic kidney disease.

Authors:  J Feehally; K E Griffith; E J Lamb; D J O'Donoghue; C R V Tomson
Journal:  BMJ       Date:  2008-10-01

3.  Prevalence of CKD in northeastern Italy: results of the INCIPE study and comparison with NHANES.

Authors:  Giovanni Gambaro; Tewoldemedhn Yabarek; Maria Stella Graziani; Alessandro Gemelli; Cataldo Abaterusso; Anna Chiara Frigo; Nicola Marchionna; Lorenzo Citron; Luciana Bonfante; Francesco Grigoletto; Salvatore Tata; Pietro Manuel Ferraro; Angelo Legnaro; Gina Meneghel; Piero Conz; Paolo Rizzotti; Angela D'Angelo; Antonio Lupo
Journal:  Clin J Am Soc Nephrol       Date:  2010-09-02       Impact factor: 8.237

Review 4.  Chronic renal diseases: renoprotective benefits of renin-angiotensin system inhibition.

Authors:  Giuseppe Remuzzi; Piero Ruggenenti; Norberto Perico
Journal:  Ann Intern Med       Date:  2002-04-16       Impact factor: 25.391

5.  Chronic kidney disease progression and outcome according to serum phosphorus in mild-to-moderate kidney dysfunction.

Authors:  Antonio Bellasi; Marcora Mandreoli; Leopoldo Baldrati; Matteo Corradini; Pierpaolo Di Nicolò; Giulio Malmusi; Antonio Santoro
Journal:  Clin J Am Soc Nephrol       Date:  2011-03-10       Impact factor: 8.237

6.  Early detection of kidney disease in community settings: the Kidney Early Evaluation Program (KEEP).

Authors:  Wendy Weinstock Brown; Rosalind M Peters; Suzanne E Ohmit; William F Keane; Allan Collins; Shu-Chen Chen; Karren King; Michael J Klag; Donald A Molony; John M Flack
Journal:  Am J Kidney Dis       Date:  2003-07       Impact factor: 8.860

7.  Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis.

Authors:  Tazeen H Jafar; Paul C Stark; Christopher H Schmid; Marcia Landa; Giuseppe Maschio; Paul E de Jong; Dick de Zeeuw; Shahnaz Shahinfar; Robert Toto; Andrew S Levey
Journal:  Ann Intern Med       Date:  2003-08-19       Impact factor: 25.391

8.  The rationale and design of the AASK cohort study.

Authors:  Lawrence J Appel; John Middleton; Edgar R Miller; Michael Lipkowitz; Keith Norris; Lawrence Y Agodoa; George Bakris; Janice G Douglas; Jeanne Charleston; Jennifer Gassman; Tom Greene; Kenneth Jamerson; John W Kusek; Julia A Lewis; Robert A Phillips; Stephen G Rostand; Jackson T Wright
Journal:  J Am Soc Nephrol       Date:  2003-07       Impact factor: 10.121

9.  Chronic Kidney Disease Japan Cohort (CKD-JAC) study: design and methods.

Authors:  Enyu Imai; Seiichi Matsuo; Hirofumi Makino; Tsuyoshi Watanabe; Tadao Akizawa; Kosaku Nitta; Satoshi Iimuro; Yasuo Ohashi; Akira Hishida
Journal:  Hypertens Res       Date:  2008-06       Impact factor: 3.872

10.  Chronic Renal Insufficiency Cohort (CRIC) Study: baseline characteristics and associations with kidney function.

Authors:  James P Lash; Alan S Go; Lawrence J Appel; Jiang He; Akinlolu Ojo; Mahboob Rahman; Raymond R Townsend; Dawei Xie; Denise Cifelli; Janet Cohan; Jeffrey C Fink; Michael J Fischer; Crystal Gadegbeku; L Lee Hamm; John W Kusek; J Richard Landis; Andrew Narva; Nancy Robinson; Valerie Teal; Harold I Feldman
Journal:  Clin J Am Soc Nephrol       Date:  2009-06-18       Impact factor: 8.237

View more
  4 in total

1.  Temporal validation of the CT-PIRP prognostic model for mortality and renal replacement therapy initiation in chronic kidney disease patients.

Authors:  Dino Gibertoni; Paola Rucci; Marcora Mandreoli; Mattia Corradini; Davide Martelli; Giorgia Russo; Elena Mancini; Antonio Santoro
Journal:  BMC Nephrol       Date:  2019-05-17       Impact factor: 2.388

2.  Medical Costs of Patients with Type 2 Diabetes in a Single Payer System: A Classification and Regression Tree Analysis.

Authors:  Paola Rucci; Vera Maria Avaldi; Claudio Travaglini; Cristina Ugolini; Elena Berti; Maria Luisa Moro; Maria Pia Fantini
Journal:  Pharmacoecon Open       Date:  2020-03

3.  Improvement Strategies for the Challenging Collaboration of General Practitioners and Specialists for Patients with Complex Chronic Conditions: A Scoping Review.

Authors:  Rebecca Tomaschek; Patricia Lampart; Anke Scheel-Sailer; Armin Gemperli; Christoph Merlo; Stefan Essig
Journal:  Int J Integr Care       Date:  2022-08-08       Impact factor: 2.913

Review 4.  Can SGLT2 inhibitors answer unmet therapeutic needs in chronic kidney disease?

Authors:  Luca De Nicola; Mario Cozzolino; Simonetta Genovesi; Loreto Gesualdo; Giuseppe Grandaliano; Roberto Pontremoli
Journal:  J Nephrol       Date:  2022-05-18       Impact factor: 4.393

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.